John O'Bryan to Antineoplastic Agents
This is a "connection" page, showing publications John O'Bryan has written about Antineoplastic Agents.
Connection Strength
1.942
-
Probing RAS Function with Monobodies. Methods Mol Biol. 2021; 2262:281-302.
Score: 0.420
-
Inhibition of RAS: proven and potential vulnerabilities. Biochem Soc Trans. 2020 10 30; 48(5):1831-1841.
Score: 0.415
-
Biology, pathology, and therapeutic targeting of RAS. Adv Cancer Res. 2020; 148:69-146.
Score: 0.406
-
Pharmacological targeting of RAS: Recent success with direct inhibitors. Pharmacol Res. 2019 01; 139:503-511.
Score: 0.361
-
Direct inhibition of RAS: Quest for the Holy Grail? Semin Cancer Biol. 2019 02; 54:138-148.
Score: 0.340